Annie Kuster said...
How might the entrance of new formulations of buprenorphine improve treatment in vulnerable populations?
Context
Kuster questions the impact of new buprenorphine formulations on treatment access.
01/28/2020
Kuster questions the impact of new buprenorphine formulations on treatment access.
01/28/2020